Q2 2019 Aclaris Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Q2 2019 Aclaris Therapeutics, Inc. Earnings Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded. It is now my pleasure to hand the conference over to Ms. Kamil Ali-Jackson, Chief Legal Officer. Ma'am, you may begin.
Thank you. I'm Kamil Ali-Jackson, Chief Legal Officer for Aclaris. Please note that earlier today, Aclaris issued its press release announcing second quarter 2019 results. For those of you who have not yet seen it, you will find a release posted in the Investors section of our website at www.aclaristx.com
.
Joining me today for the call are Dr. Neal Walker, President and Chief Executive Officer; Dr. Stuart Shanler, our Chief Scientific Officer; Frank Ruffo, our Chief Financial Officer; Dr. David Gordon, our Chief Medical Officer; and Jeff
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |